nontuberculous%20mycobacterial%20disease
NONTUBERCULOUS MYCOBACTERIAL DISEASE
Nontuberculous mycobacteria are ubiquitous and are usually found in soil, natural and treated water sources. They are relatively uncommon cause of pulmonary disease and likely to cause disseminated disease.
May cause both asymptomatic infection and symptomatic disease in humans.
There is no evidence of animal-to-human or human-to-human transmission in immunocompetent hosts.
Nontuberculous mycobacterial pulmonary disease is a generally slowly progressive infection.
Signs and symptoms are generally nonspecific.
Drug Information

Indication: Infections caused by clarithromycin-sensitive pathogens: Nasopharynx (eg, tonsillitis, pharyngitis), paranasal...

Indication: Upper resp tract infections eg, strep pharyngitis/tonsillitis, acute maxillary sinusitis; lower resp tract inf...

Indication: Bronchitis, community-acquired pneumonia, sinusitis, pharyngitis, otitis media, skin & soft tissue infecti...

Indication: Acute sinusitis & exacerbation of chronic bronchitis. Community-acquired pneumonia. Mild to moderately sev...

Indication: Tonsillitis, pharyngitis, sinusitis, lower resp tract infections (bronchitis, bacterial & atypical pneumon...

Indication: In conjunction w/ other anti-TB drugs in the treatment of all forms of TB.

Indication: Community-acquired pneumonia (CAP) caused by susceptible organisms eg, Legionella pneumophila & pelvic inf...

Indication: Lower resp tract infections including bronchitis & pneumonia; skin & soft tissue infections; acute oti...

Akurit-4
ethambutol hydrochloride + isoniazid + pyrazinamid...
2  /  5
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
15 Jun 2019
New drug applications approved by US FDA as of 01 - 15 June 2019 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.